Latest Options News

VRX Silica Limited has successfully concluded the environmental appeal process for its Arrowsmith North Silica Sand Project, with the WA Minister for Environment confirming the adequacy of the EPA assessment. The company is now advancing financing discussions and offtake agreements as it awaits formal project approval.

WIN Metals Ltd has significantly expanded its Butchers Creek gold resource, boosting indicated ounces by 86% and advancing the project towards economic evaluation. Concurrent exploration successes and strategic asset sales underpin the company’s focused growth strategy.

Diablo Resources Limited reported a cash outflow for the June 2025 quarter, with limited cash reserves and plans underway to secure additional funding to sustain its exploration activities.

Diablo Resources advances exploration at its Phoenix Copper Project with significant rock sampling results and drill permits granted for key prospects, setting the stage for drilling in Q3 2025.

Saferoads Holdings reports a $192k operating cash use impacted by strategic prepayments, completes its Road Safety Rentals asset sale, and maintains strong cash reserves after paying a substantial dividend.

Chariot Corporation has secured a 66.7% stake in one of Nigeria’s largest hard-rock lithium portfolios, backed by a A$1.6 million capital raise and a new working capital facility, marking a strategic move into the Africa–China lithium corridor.

Arovella Therapeutics reported a robust $20.9 million cash position as it prepares for its first-in-human trial of ALA-101 and expands its solid tumour pipeline through new licensing agreements and leadership appointments.

Brightstar Resources secures backing from major Aurumin shareholders and option holders for its proposed acquisition, pending expert approval and absence of superior offers.

Moab Minerals is progressing its Manyoni uranium project with a planned JORC-compliant resource estimate and is nearing completion of a key tenement acquisition, while securing fresh funding to support ongoing exploration.

Alterity Therapeutics has reported encouraging topline results from its open-label Phase 2 trial of ATH434 in advanced Multiple System Atrophy, showing slowed disease progression and biomarker stabilization.

Kula Gold has reported its first JORC-compliant inferred resource estimate for the Mt Palmer Gold Mine tailings, revealing nearly 2,000 ounces of gold with promising recovery rates. The resource’s proximity to existing processing infrastructure could accelerate monetisation options.

Noxopharm Limited has successfully completed the first low-dose cohort in its HERACLES clinical trial for SOF-SKN™, clearing the way for higher dose testing in autoimmune disease treatment.